PMC:7441788 / 37496-37914 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T150","span":{"begin":23,"end":31},"obj":"Disease"}],"attributes":[{"id":"A150","pred":"mondo_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T272","span":{"begin":186,"end":188},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T273","span":{"begin":208,"end":209},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T274","span":{"begin":262,"end":264},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T275","span":{"begin":323,"end":325},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T276","span":{"begin":399,"end":401},"obj":"http://purl.obolibrary.org/obo/CLO_0007874"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T383","span":{"begin":142,"end":154},"obj":"Chemical"},{"id":"T384","span":{"begin":301,"end":313},"obj":"Chemical"}],"attributes":[{"id":"A383","pred":"chebi_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A384","pred":"chebi_id","subj":"T384","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T220","span":{"begin":142,"end":154},"obj":"Chemical"},{"id":"T221","span":{"begin":301,"end":313},"obj":"Chemical"}],"attributes":[{"id":"A220","pred":"chebi_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A221","pred":"chebi_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T136","span":{"begin":23,"end":31},"obj":"Species"}],"attributes":[{"id":"A136","pred":"ncbi_taxonomy_id","subj":"T136","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T257","span":{"begin":0,"end":418},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1347","span":{"begin":32,"end":40},"obj":"Species"},{"id":"1348","span":{"begin":103,"end":111},"obj":"Species"},{"id":"1349","span":{"begin":193,"end":201},"obj":"Species"},{"id":"1350","span":{"begin":271,"end":279},"obj":"Species"},{"id":"1373","span":{"begin":122,"end":125},"obj":"Chemical"},{"id":"1374","span":{"begin":142,"end":154},"obj":"Chemical"},{"id":"1375","span":{"begin":293,"end":296},"obj":"Chemical"},{"id":"1376","span":{"begin":301,"end":313},"obj":"Chemical"},{"id":"1377","span":{"begin":353,"end":356},"obj":"Chemical"},{"id":"1414","span":{"begin":23,"end":31},"obj":"Disease"}],"attributes":[{"id":"A1375","pred":"pubann:denotes","subj":"1375","obj":"MESH:D006886"},{"id":"A1414","pred":"pubann:denotes","subj":"1414","obj":"MESH:C000657245"},{"id":"A1374","pred":"pubann:denotes","subj":"1374","obj":"MESH:D017963"},{"id":"A1348","pred":"pubann:denotes","subj":"1348","obj":"Tax:9606"},{"id":"A1349","pred":"pubann:denotes","subj":"1349","obj":"Tax:9606"},{"id":"A1350","pred":"pubann:denotes","subj":"1350","obj":"Tax:9606"},{"id":"A1347","pred":"pubann:denotes","subj":"1347","obj":"Tax:9606"},{"id":"A1376","pred":"pubann:denotes","subj":"1376","obj":"MESH:D017963"},{"id":"A1373","pred":"pubann:denotes","subj":"1373","obj":"MESH:D006886"},{"id":"A1377","pred":"pubann:denotes","subj":"1377","obj":"MESH:D006886"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T143","span":{"begin":23,"end":31},"obj":"Disease"}],"attributes":[{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1347","span":{"begin":32,"end":40},"obj":"Species"},{"id":"1348","span":{"begin":103,"end":111},"obj":"Species"},{"id":"1349","span":{"begin":193,"end":201},"obj":"Species"},{"id":"1350","span":{"begin":271,"end":279},"obj":"Species"},{"id":"1373","span":{"begin":122,"end":125},"obj":"Chemical"},{"id":"1374","span":{"begin":142,"end":154},"obj":"Chemical"},{"id":"1375","span":{"begin":293,"end":296},"obj":"Chemical"},{"id":"1376","span":{"begin":301,"end":313},"obj":"Chemical"},{"id":"1377","span":{"begin":353,"end":356},"obj":"Chemical"},{"id":"1414","span":{"begin":23,"end":31},"obj":"Disease"}],"attributes":[{"id":"A1347","pred":"tao:has_database_id","subj":"1347","obj":"Tax:9606"},{"id":"A1348","pred":"tao:has_database_id","subj":"1348","obj":"Tax:9606"},{"id":"A1349","pred":"tao:has_database_id","subj":"1349","obj":"Tax:9606"},{"id":"A1350","pred":"tao:has_database_id","subj":"1350","obj":"Tax:9606"},{"id":"A1373","pred":"tao:has_database_id","subj":"1373","obj":"MESH:D006886"},{"id":"A1374","pred":"tao:has_database_id","subj":"1374","obj":"MESH:D017963"},{"id":"A1375","pred":"tao:has_database_id","subj":"1375","obj":"MESH:D006886"},{"id":"A1376","pred":"tao:has_database_id","subj":"1376","obj":"MESH:D017963"},{"id":"A1377","pred":"tao:has_database_id","subj":"1377","obj":"MESH:D006886"},{"id":"A1414","pred":"tao:has_database_id","subj":"1414","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T257","span":{"begin":0,"end":418},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]."}